• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者芳香化酶抑制剂所致关节痛治疗的临床疗效比较:一项网状Meta分析的系统评价

Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis.

作者信息

Bae Kyeore, Lamoury Gillian, Carroll Susan, Morgia Marita, Lim Stephanie, Baron-Hay Sally, Shin In-Soo, Park So-Jung, Oh Byeongsang

机构信息

Integrative Cancer Center, Doban Hospital, Seoul, 03170, Republic of Korea; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, Sydney, New South Wales, 2065, Australia.

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, Sydney, New South Wales, 2065, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, 2006, Australia.

出版信息

Crit Rev Oncol Hematol. 2023 Jan;181:103898. doi: 10.1016/j.critrevonc.2022.103898. Epub 2022 Dec 16.

DOI:10.1016/j.critrevonc.2022.103898
PMID:36535489
Abstract

Aromatase inhibitor-induced arthralgia (AIA) contributes to poor adherence of aromatase inhibitor therapies in patients with breast cancer. A systematic review using network meta-analysis (NMA) was conducted to examine the clinical effectiveness of multiple therapies and rank probabilities for the management of AIA. Randomized controlled trials (RCTs) assessing treatments for AIA in postmenopausal women with stage 0-III hormone receptor-positive breast cancer were searched from inception to October 2021. The main NMA involved 1516 participants from 17 RCTs. Acupuncture was the highest ranked intervention to improve pain intensity followed by sham acupuncture, multicomponent herbal medicine, exercise, duloxetine, vitamin D, omega-3 fatty acids, physical therapy, testosterone, and inactive controls. Single natural products were inferior to controls. The current review provides new insights into the management of AIA in breast cancer survivors for increased survival and can be utilized to make evidence-based decisions regarding treatment.

摘要

芳香化酶抑制剂所致关节痛(AIA)导致乳腺癌患者对芳香化酶抑制剂治疗的依从性较差。进行了一项采用网状Meta分析(NMA)的系统评价,以检验多种治疗方法的临床疗效,并对AIA管理的可能性进行排序。检索了从开始到2021年10月评估0-III期激素受体阳性绝经后乳腺癌女性AIA治疗方法的随机对照试验(RCT)。主要的NMA纳入了来自17项RCT的1516名参与者。针灸是改善疼痛强度排名最高的干预措施,其次是假针灸、多成分草药、运动、度洛西汀、维生素D、ω-3脂肪酸、物理治疗、睾酮和无活性对照。单一天然产物不如对照。本综述为提高乳腺癌幸存者的生存率提供了关于AIA管理的新见解,可用于做出基于证据的治疗决策。

相似文献

1
Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis.乳腺癌患者芳香化酶抑制剂所致关节痛治疗的临床疗效比较:一项网状Meta分析的系统评价
Crit Rev Oncol Hematol. 2023 Jan;181:103898. doi: 10.1016/j.critrevonc.2022.103898. Epub 2022 Dec 16.
2
Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis.比较芳香化酶抑制剂引起的乳腺癌患者关节痛治疗效果的临床研究:系统评价和网络荟萃分析方案。
BMJ Open. 2020 May 4;10(5):e033461. doi: 10.1136/bmjopen-2019-033461.
3
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
4
Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.乳腺癌幸存者芳香化酶抑制剂相关关节痛的治疗干预措施:一项系统评价和荟萃分析
Cancer Nurs. 2017 Jul/Aug;40(4):E26-E41. doi: 10.1097/NCC.0000000000000409.
5
Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis.芳香化酶抑制剂所致乳腺癌关节痛的患病率:一项系统评价与荟萃分析
Support Care Cancer. 2017 May;25(5):1673-1686. doi: 10.1007/s00520-017-3613-z. Epub 2017 Feb 15.
6
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.芳香化酶抑制剂用于治疗绝经后妇女的晚期乳腺癌。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003370. doi: 10.1002/14651858.CD003370.pub2.
7
Hormonal therapies for early breast cancer: systematic review and economic evaluation.早期乳腺癌的激素疗法:系统评价与经济学评估
Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. doi: 10.3310/hta11260.
8
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.

引用本文的文献

1
Chinese Medicines Treatment for Sleep Disturbance in Breast Cancer Survivors: A Network Meta-Analysis.中药治疗乳腺癌幸存者睡眠障碍的网状Meta分析。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241308857. doi: 10.1177/15347354241308857.
2
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.妇科肿瘤协作组《早期乳腺癌患者诊断与治疗建议:2024年更新》
Breast Care (Basel). 2024 Jun;19(3):165-182. doi: 10.1159/000538596. Epub 2024 Apr 18.
3
Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the literature.
地中海饮食和持续血糖监测指导下的积极生活方式改善芳香化酶抑制剂所致关节痛:一例报告及文献综述
Front Oncol. 2024 Feb 1;14:1189287. doi: 10.3389/fonc.2024.1189287. eCollection 2024.
4
Current Perspectives and Trend of Acupuncture in Breast Cancer-Related Symptoms: A Bibliometric Study.针灸治疗乳腺癌相关症状的现状与趋势:一项文献计量学研究
J Pain Res. 2023 Dec 5;16:4165-4180. doi: 10.2147/JPR.S442151. eCollection 2023.